Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus

This study has been completed.
Information provided by:
Deutsches Herzzentrum Muenchen Identifier:
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
The purpose of this study was to evaluate the performance of established and new risk predictors in predicting mortality in post-infarction patients suffering from diabetes mellitus

Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus

Further study details as provided by Deutsches Herzzentrum Muenchen:

Estimated Enrollment: 650
Study Start Date: January 1995

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

acute myocardial infarction, presence of sinusrhythm

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00196235

Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
1. Medizinische Klinik, Klinikum rechts der Isar
Munich, Germany, 81675
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Study Chair: Georg Schmidt, MD Deutsches Herzzentrum Muenchen
Study Director: Petra Barthel, MD Deutsches Herzzentrum Muenchen
Principal Investigator: Axel Bauer, MD Deutsches Herzzentrum Muenchen
  More Information

Additional Information:
Publications: Identifier: NCT00196235     History of Changes
Other Study ID Numbers: GE IDE No. R00295 
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Deutsches Herzzentrum Muenchen:
Assessment, Risk
Diabetes mellitus
Autonomic nervous system

Additional relevant MeSH terms:
Diabetes Mellitus
Myocardial Infarction
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on October 25, 2016